44 related articles for article (PubMed ID: 30098780)
1. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract][Full Text] [Related]
2. Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care - A systematic review.
Cohen O; Tzelnick S; Randolph G; Rinaldo A; Álvarez F; Rodrigo JP; Saba NF; Nuyts S; Corry J; Mäkitie AA; Vander Poorten V; Nathan CA; Piazza C; Ferlito A
Clin Endocrinol (Oxf); 2024 May; 100(5):468-476. PubMed ID: 38472743
[TBL] [Abstract][Full Text] [Related]
3. Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000-2020: a population-based retrospective cohort study.
Tao Z; Deng X; Guo B; Ding Z; Fan Y
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38376827
[TBL] [Abstract][Full Text] [Related]
4. Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry.
Cox C; Chen Y; Cress R; Semrad AM; Semrad T; Gosnell JE; Campbell MJ
Gland Surg; 2016 Aug; 5(4):398-404. PubMed ID: 27563561
[TBL] [Abstract][Full Text] [Related]
5. Reply to Letter to the Editor regarding "Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer".
Maniakas A; Hu MI; Gunn GB; Zafereo M
Head Neck; 2024 Jul; 46(7):1848-1849. PubMed ID: 38646970
[No Abstract] [Full Text] [Related]
6. Evidence for postoperative radiotherapy in medullary thyroid cancer.
Rowell NP
Head Neck; 2024 Jul; 46(7):1846-1847. PubMed ID: 38646954
[No Abstract] [Full Text] [Related]
7. Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract][Full Text] [Related]
8. Precision Thyroidectomy in Sporadic Medullary Thyroid Cancer.
Shaha AR; Davies L; Tuttle RM
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):215-216. PubMed ID: 38270970
[No Abstract] [Full Text] [Related]
9. Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System.
Shen C; Shi X; Wen D; Zhang Y; Du Y; Zhang Y; Ma B; Tang H; Yin M; Huang N; Liao T; Zhang TT; Kong C; Wei W; Ji Q; Wang Y
Clin Cancer Res; 2024 Jan; 30(1):127-138. PubMed ID: 37931242
[TBL] [Abstract][Full Text] [Related]
10. [Thyroid carcinoma: epidemiological, clinical and therapeutic profiles, about 102 cases].
Touati MM; Aljalil A; Darouassi Y; Chihani M; Lahkim M; Fihri JA; Bouaity B; Ammar H
Pan Afr Med J; 2015; 21():59. PubMed ID: 26405495
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for preoperative estimation risk of cervical lymph node metastasis in medullary thyroid carcinoma.
Luo Z; Hong Y; Yan C; Ye Q; Wang Y; Huang P
Front Oncol; 2022; 12():883429. PubMed ID: 36313643
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology.
Jassal K; Ravintharan N; Prabhakaran S; Grodski S; Serpell JW; Lee JC
ANZ J Surg; 2022 Jun; 92(6):1428-1433. PubMed ID: 35412008
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer.
Parikh R; Hess LM; Esterberg E; Bhandari NR; Kaye JA
Thyroid Res; 2022 Feb; 15(1):2. PubMed ID: 35151352
[TBL] [Abstract][Full Text] [Related]
14. Effects of marital status on survival of medullary thyroid cancer stratified by age.
Ai L; Li N; Tan HL; Wei B; Zhao YX; Chen P; Hu HY; Liu M; Ou-Yang DJ; Qin ZE; Huang P; Chang S
Cancer Med; 2021 Dec; 10(24):8829-8837. PubMed ID: 34723436
[TBL] [Abstract][Full Text] [Related]
15. New proposed tumor-node-metastasis staging system for medullary thyroid carcinoma based on the Surveillance, Epidemiology, and End Results database.
Wang M; Hu D; Zeng W; Chen S; Huang Y; Zhou L; Zhou W; Wei W; Zhang C; Liu Z; Guo L
Am J Transl Res; 2020; 12(6):2703-2710. PubMed ID: 32655802
[TBL] [Abstract][Full Text] [Related]
16. Risk and survival of patients with medullary thyroid cancer: National perspective.
Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
[TBL] [Abstract][Full Text] [Related]
17. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
